880 related articles for article (PubMed ID: 17948613)
21. The place of COMT inhibitors in the armamentarium of drugs for the treatment of Parkinson's disease.
Schapira AH; Obeso JA; Olanow CW
Neurology; 2000; 55(11 Suppl 4):S65-8; discussion S69-71. PubMed ID: 11147512
[TBL] [Abstract][Full Text] [Related]
22. Entacapone, a catechol-O-methyltransferase inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson's disease induced by Japanese encephalitis virus.
Hamaue N; Ogata A; Terado M; Tsuchida S; Yabe I; Sasaki H; Hirafuji M; Togashi H; Aoki T
Brain Res; 2010 Jan; 1309():110-5. PubMed ID: 19879254
[TBL] [Abstract][Full Text] [Related]
23. Other pharmacological treatments for motor complications and dyskinesias.
Waters C
Mov Disord; 2005; 20 Suppl 11():S38-44. PubMed ID: 15822104
[TBL] [Abstract][Full Text] [Related]
24. 'Bad guys' among the antiparkinsonian drugs.
Pirtosek Z
Psychiatr Danub; 2009 Mar; 21(1):114-8. PubMed ID: 19270634
[TBL] [Abstract][Full Text] [Related]
25. Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-release.
Rascol O
Eur J Neurol; 2011 Mar; 18 Suppl 1():3-10. PubMed ID: 21255197
[TBL] [Abstract][Full Text] [Related]
26. Medical treatment of later-stage motor problems of Parkinson disease.
Ahlskog JE
Mayo Clin Proc; 1999 Dec; 74(12):1239-54. PubMed ID: 10593354
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular and mortality risks in Parkinson's disease patients treated with entacapone.
Graham DJ; Williams JR; Hsueh YH; Calia K; Levenson M; Pinheiro SP; Macurdy TE; Shih D; Worrall C; Kelman JA
Mov Disord; 2013 Apr; 28(4):490-7. PubMed ID: 23443994
[TBL] [Abstract][Full Text] [Related]
28. Interventions to achieve tonic exposure to levodopa: delaying or preventing the onset of motor complications.
Luer MS
Pharmacotherapy; 1999 Nov; 19(11 Pt 2):169S-79S. PubMed ID: 10555945
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-off.
Kuoppamäki M; Leinonen M; Poewe W
J Neural Transm (Vienna); 2015 Dec; 122(12):1709-14. PubMed ID: 26347184
[TBL] [Abstract][Full Text] [Related]
30. Off spells and dyskinesias: pharmacologic management of motor complications.
Khan TS
Cleve Clin J Med; 2012 Jul; 79 Suppl 2():S8-13. PubMed ID: 22761271
[TBL] [Abstract][Full Text] [Related]
31. [Treatment in Parkinson disease].
Takáts A
Orv Hetil; 2004 Apr; 145(15):833-4. PubMed ID: 15188639
[No Abstract] [Full Text] [Related]
32. Parkinson's disease therapy: treatment of early and late disease.
Jankovic J
Chin Med J (Engl); 2001 Mar; 114(3):227-34. PubMed ID: 11780303
[TBL] [Abstract][Full Text] [Related]
33. Treatment of Parkinson's disease in Thailand: review of the literature and practical recommendations.
Bhidayasiri R; Ling H
J Med Assoc Thai; 2009 Jan; 92(1):142-54. PubMed ID: 19260256
[TBL] [Abstract][Full Text] [Related]
34. Current and experimental treatments of Parkinson disease: A guide for neuroscientists.
Oertel W; Schulz JB
J Neurochem; 2016 Oct; 139 Suppl 1():325-337. PubMed ID: 27577098
[TBL] [Abstract][Full Text] [Related]
35. Advanced strategies for treatment of Parkinson's disease: the role of early treatment.
Jann MW
Am J Manag Care; 2011 Oct; 17 Suppl 12():S315-21. PubMed ID: 22087552
[TBL] [Abstract][Full Text] [Related]
36. How should we treat a patient with early Parkinson's disease?
Tsouli S; Konitsiotis S
Int J Clin Pract; 2010 Aug; 64(9):1210-9. PubMed ID: 20653797
[TBL] [Abstract][Full Text] [Related]
37. Parkinson's disease: diagnosis and treatment.
Rao SS; Hofmann LA; Shakil A
Am Fam Physician; 2006 Dec; 74(12):2046-54. PubMed ID: 17186710
[TBL] [Abstract][Full Text] [Related]
38. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
Jankovic J; Stacy M
CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
[TBL] [Abstract][Full Text] [Related]
39. Entacapone in the treatment of Parkinson's disease.
Schrag A
Lancet Neurol; 2005 Jun; 4(6):366-70. PubMed ID: 15907741
[TBL] [Abstract][Full Text] [Related]
40. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]